Klingenstein Fields & Co’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$391K Buy
7,178
+178
+3% +$8.67K 0.01% 149
2026
Q1
$300K Hold
7,000
0.01% 150
2025
Q4
$307K Hold
7,000
0.01% 150
2025
Q3
$289K Hold
7,000
0.01% 161
2025
Q2
$309K Hold
7,000
0.01% 147
2025
Q1
$258K Hold
7,000
0.01% 160
2024
Q4
$233K Buy
+7,000
New +$227K 0.01% 166
2018
Q1
Sell
-7,000
Closed -$213K 223
2017
Q4
$213K Buy
+7,000
New +$186K 0.01% 213
2017
Q3
Sell
-9,000
Closed -$222K 221
2017
Q2
$222K Sell
9,000
-993
-10% -$21K 0.01% 208
2017
Q1
$217K Buy
+9,993
New +$203K 0.01% 207
2015
Q4
Sell
-12,993
Closed -$73K 224
2015
Q3
$73K Hold
12,993
﹤0.01% 227
2015
Q2
$49K Hold
12,993
﹤0.01% 249
2015
Q1
$33K Hold
12,993
﹤0.01% 249
2014
Q4
$19K Sell
12,993
-3,140
-19% -$4.89K ﹤0.01% 244
2014
Q3
$25K Hold
16,133
﹤0.01% 244
2014
Q2
$55K Hold
16,133
﹤0.01% 250
2014
Q1
$57K Hold
16,133
﹤0.01% 250
2013
Q4
$99K Hold
16,133
﹤0.01% 304
2013
Q3
$94K Hold
16,133
﹤0.01% 301
2013
Q2
$73K Buy
+16,133
New +$76.5K ﹤0.01% 313

Other funds holding EXEL

Klingenstein Fields & Co's EXEL Position: Q2 2026 in Review

Klingenstein Fields & Co increased its Exelixis (EXEL) stake by 2.5% in Q2 2026, buying an estimated $8.67K and bringing the position to 7,178 shares worth $391K. The position accounts for 0.01% of the portfolio, ranked #149.

Klingenstein Fields & Co first reported a position in EXEL in Q2 2013 and has held it in 20 quarters since. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Klingenstein Fields & Co held 7,178 shares of Exelixis worth $391K as of Q2 2026.
  • Klingenstein Fields & Co bought 178 Exelixis shares in Q2 2026, an estimated $8.67K.
  • Exelixis made up 0.01% of Klingenstein Fields & Co's portfolio in Q2 2026, its #149 holding.
  • Klingenstein Fields & Co first reported a position in Exelixis in Q2 2013 and has held it in 20 quarters since.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Klingenstein Fields & Co's 13F filing for Q2 2026, filed 5 Aug 2026.